These data indicate that (i) FBLN5 gene expression is absent in malignant ovarian epithelial cells but may be expressed in other cell types within the tumor, and (ii) epithelial ovarian cancer cells do not metabolize FBLN5. Here, FBLN5 is linked to ovarian carcinoma.